Octreotide in Treating Patients With Cancer-Related Malignant Ascites
Study Information
Alliance Study ID: NCCTG-N04C2
NCT Study ID (ClinicalTrials.gov): NCT00182754
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Aminah Jatoi, MD
Status: COMPLETED
Study Description
RATIONALE: Octreotide may be an effective treatment for malignant ascites. It is not yet known whether octreotide is more effective than a placebo in treating malignant ascites.
PURPOSE: This randomized phase III trial is studying octreotide to see how well it works compared to placebo in treating patients with cancer-related malignant ascites.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information